Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05018247 · ClinicalTrials.gov registry record · NA
Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05018247: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT05018247 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05018247, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.
Primary Outcome
CFCblue is defined as a dipyridamole induced stress flow ≤ 0.83 ml/min/g of myocardium and a CFR ≤ 1.27.
Interventions
- PROCEDURE Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2022-05-19 |
| Phase | NA |
Why NCT05018247 stopped before completion
NCT05018247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention is the first listed.
NCT05018247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05018247 about?
NCT05018247 is a clinical study titled "Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging". To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.
What is the current status of trial NCT05018247?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2021-05-04. Estimated completion is 2022-05-19.
What interventions are being tested in trial NCT05018247?
The interventions under investigation include: Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention (PROCEDURE).
Who is sponsoring clinical trial NCT05018247?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05018247's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy